dronabinol has been researched along with Carcinoma, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anil, SM; Anis, O; Belausov, E; Cohen, O; Koltai, H; Mayzlish Gati, E; Nadarajan, S; Namdar, D; Ramon, J; Shalev, N; Vinayaka, AC | 1 |
| Hernandez, SL; Sheyner, I; Stewart, JT; Stover, KT | 1 |
| Carchenilla, MS; Jacobsson, SO; Johansson, M; Persson, E; Svensson, AC | 1 |
| Moyer, MP; Robertson, DA; Ward, SG; Wright, KL | 1 |
4 other study(ies) available for dronabinol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization.
Topics: Cannabinoids; Cannabis; Carcinoma; Cell Movement; Cytoskeleton; Cytotoxins; Dronabinol; Humans; Urothelium | 2021 |
Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
Topics: Antiemetics; Carcinoma; Dronabinol; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Peritoneal Neoplasms; Vomiting | 2015 |
Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Benzoxazines; Blotting, Western; Calcium; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; gamma-Aminobutyric Acid; Gene Expression; Mice; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temperature; Tretinoin; Tritium | 2006 |
Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
Topics: Adenoma; Anti-Obesity Agents; Apoptosis; Carcinoma; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dronabinol; Drug Inverse Agonism; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2008 |